Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Pharmaceuticals & Biotech
Create a narrative
Evotec Community
XTRA:EVT Community
1
Narratives
written by author
0
Comments
on narratives written by author
33
Fair Values set
on narratives written by author
Create a narrative
Evotec
Popular
Undervalued
Overvalued
Community Investing Ideas
Evotec
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Pharmaceutical Collaborations And Cost Savings Will Drive Excellence
Key Takeaways Strengthened partnerships with major pharma companies and a focus on biologics manufacturing are expected to boost Evotec's revenue and earnings. Cost-saving initiatives and refocused R&D spending on proprietary technology are likely to enhance net margins and drive profitability.
View narrative
€11.80
FV
37.7% undervalued
intrinsic discount
9.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
EVT
EVT
Evotec
Your Fair Value
€
Current Price
€7.35
53.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-207m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.3b
Earnings €151.5m
Advanced
Set Fair Value